Business · 15/07/2020Updated: 10/17/2026 · 1 min read
FDA Adds Brucellosis to List of Designated Tropical Diseases Eligible for Priority Review Vouchers
Summary
The US Food and Drug Administration (FDA) has designated brucellosis as a tropical disease, making its product applications eligible for priority review vouchers (PRVs), which can expedite the review process for applicants
Original source language: Federal Register — Food and Drug AdministrationOpen original release →